An overview of Dent disease
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Dent disease is a rare inherited kidney tubulopathy caused by mutations in either the CLCN5 (Dent disease 1) or OCRL1 (Dent disease 2) genes, and which is often underdiagnosed in practice. A diagnosis is clinically suspected in patients with low-molecular-weight proteinuria, hypercalciuria, and one of the following: hematuria, nephrolithiasis, nephrocalcinosis, hypophosphatemia, or chronic kidney disease. Inheritance is X-linked recessive, meaning, these symptoms are generally only found in males; female carriers may have mild phenotypes. Genetic testing is only a method to confirm the diagnosis, approximately 25% to 35% of patients have neither the CLCN5 nor OCRL1 pathogenic variants (Dent disease 3), making diagnosis more challenging. The genotype-phenotype correlations are not evident with the limited clinical data available. As with many other genetic diseases, the management of patients with Dent disease concentrates on symptom relief rather than any causative process. The current treatments are mainly supportive to reduce hypercalciuria and prevent nephrolithiasis. Chronic kidney disease progresses to end-stage between the ages of the third to fifth decades in 30% to 80% of affected males. In this review, we aimed to summarize the literature on Dent disease and reveal the clinical characteristics and molecular basis of Korean patients with Dent disease.
Abstract
Dent disease is a rare inherited kidney tubulopathy caused by mutations in either the CLCN5 (Dent disease 1) or OCRL1 (Dent disease 2) genes, and which is often underdiagnosed in practice. A diagnosis is clinically suspected in patients with low-molecular-weight proteinuria, hypercalciuria, and one of the following: hematuria, nephrolithiasis, nephrocalcinosis, hypophosphatemia, or chronic kidney disease. Inheritance is X-linked recessive, meaning, these symptoms are generally only found in males; female carriers may have mild phenotypes. Genetic testing is only a method to confirm the diagnosis, approximately 25% to 35% of patients have neither the CLCN5 nor OCRL1 pathogenic variants (Dent disease 3), making diagnosis more challenging. The genotype-phenotype correlations are not evident with the limited clinical data available. As with many other genetic diseases, the management of patients with Dent disease concentrates on symptom relief rather than any causative process. The current treatments are mainly supportive to reduce hypercalciuria and prevent nephrolithiasis. Chronic kidney disease progresses to end-stage between the ages of the third to fifth decades in 30% to 80% of affected males. In this review, we aimed to summarize the literature on Dent disease and reveal the clinical characteristics and molecular basis of Korean patients with Dent disease.
참고문헌 (34)
- Wrong OM, "Dent's disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance", QJM, 87, pp.473~493 (1994)
- Dent CE, "Hypophosphataemic osteomalacia with complete recovery", Br Med J, 1, pp.1676~1679 (1964)
- Frymoyer PA, "X-linked recessive nephrolithiasis with renal failure", N Engl J Med, 325, pp.681~686 (1991)
- Lloyd SE, "A common molecular basis for three inherited kidney stone diseases", Nature, 379, pp.445~449 (1996)
- Devuyst O, "Dent's disease", Orphanet J Rare Dis, 5, pp.28~ (2010)
- Scheinman SJ, "X-linked hypercalciuric nephrolithiasis : clinical syndromes and chloride channel mutations", Kidney Int, 53, pp.3~17 (1998)
- Ye Q, "Multicenter study of the clinical features and mutation gene spectrum of Chinese children with Dent disease", Clin Genet, 97, pp.407~417 (2020)
- Sekine T, "Japanese Dent disease has a wider clinical spectrum than Dent disease in Europe", USA : genetic and clinical studies of 86 unrelated patients with low-molecular-weight proteinuria, 2014, pp.29, 376~384
- Zaniew M, "Dent disease in Poland: what we have learned so far?", Int Urol Nephrol, 49, pp.2005~2017 (2017)
- Blanchard A, "Observations of a large Dent disease cohort", Kidney Int, 90, pp.430~439 (2016)
- Hoopes RR, "Evidence for genetic heterogeneity in Dent's disease", Kidney Int, 65, pp.1615~1620 (2004)
- Hoopes RR, "Dent disease with mutations in OCRL1", Am J Hum Genet, 76, pp.260~267 (2005)
- Anglani F, "Nephrolithiasis, kidney failure and bone disorders in Dent disease patients with and without CLCN5 mutations", Springerplus, 4, pp.492~ (2015)
- Poroca DR, "ClC channels and transporters:structure, physiological functions, and implications in human chloride channelopathies", Front Pharmacol, 8, pp.151~ (2017)
- Wang Y, "ClC-5 : role in endocytosis in the proximal tubule", Am J Physiol Renal Physiol, 289, pp.F850~62 (2005)
- Jin YY, "Dent disease: classification, heterogeneity and diagnosis", World J Pediatr, 17, pp.52~57 (2021)
- Gianesello L, "From protein uptake to Dent disease : an overview of the CLCN5 gene", Gene, 747, pp.144662~ (2020)
- Mansour-Hendili L, "Mutation update of the CLCN5 gene responsible for Dent disease 1", Hum Mutat, 36, pp.743~752 (2015)
- Attree O, "The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase", Nature, 358, pp.239~242 (1992)
- Claverie-Martin F, "Dent's disease : clinical features and molecular basis", Pediatr Nephrol, 26, pp.693~704 (2011)
- Raucher D, "Phosphatidylinositol 4,5-bisphosphate functions as a second messenger that regulates cytoskeleton-plasma membrane adhesion", Cell, 100, pp.221~228 (2000)
- Oltrabella F, "The Lowe syndrome protein OCRL1 is required for endocytosis in the zebrafish pronephric tubule", PLoS Genet, 11, pp.e1005058~ (2015)
- Shrimpton AE, "OCRL1 mutations in Dent 2 patients suggest a mechanism for phenotypic variability", Nephron Physiol, 112, pp.27~36 (2009)
- Lloyd SE, "Characterisation of renal chloride channel, CLCN5, mutations in hypercalciuric nephrolithiasis (kidney stones) disorders", Hum Mol Genet, 6, pp.1233~1239 (1997)
- van Berkel Y, "Proteinuria in Dent disease : a review of the literature", Pediatr Nephrol, 32, pp.1851~1859 (2017)
- Gianesello L, "Genetics and phenotypic heterogeneity of Dent disease : the dark side of the moon", Hum Genet, 140, pp.401~421 (2021)
- Devuyst O, "Genetics of hypercalciuric stone forming diseases", Kidney Int, 72, pp.1065~1072 (2007)
- Bokenkamp A, "Dent-2 disease : a mild variant of Lowe syndrome", J Pediatr, 155, pp.94~99 (2009)
- Sayer JA, "Calcium phosphate and calcium oxalate crystal handling is dependent upon CLC-5 expression in mouse collecting duct cells", Biochim Biophys Acta, 1689, pp.83~90 (2004)
- Scheinman SJ, "Genetic disease of the kidney", pp.213~226 (2009), Elsevier Inc
- Ehlayel AM, "Update on Dent disease", Pediatr Clin North Am, 66, pp.169~178 (2019)
- Raja KA, "Responsiveness of hypercalciuria to thiazide in Dent's disease", J Am Soc Nephrol, 13, pp.2938~2944 (2002)
- Blanchard A, "Effect of hydrochlorothiazide on urinary calcium excretion in dent disease : an uncontrolled trial", Am J Kidney Dis, 52, pp.1084~1095 (2008)
- Frishberg Y, "Dent's disease manifesting as focal glomerulosclerosis:Is it the tip of the iceberg?", Pediatr Nephrol, 24, pp.2369~2373 (2009)